Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma

1. Reynés, G.
2. Martínez-Sales, V.
3. Vila, V.
4. Balañá, C.
5. Pérez-Segura, P.
6. Vaz, M.A.
7. Benavides, M.
8. Gallego, O.
9. Palomero, I.
10. Gil-Gil, M.
11. Fleitas, T.
12. Reche, E.